Atara Biotherapeutics, Inc. (ATRA) has seen some recent activity in the stock market and its common shares finished trading at $14.02 yesterday. Investors are starting to take interest of ATRA as the common shares traded as high as $14.09 and as low as $12.86 in the previous trading session.

Atara Biotherapeutics, Inc. (ATRA) average trading volume is 1.56M. However, in the previous trading session Atara Biotherapeutics, Inc. (ATRA) traded 2,737,103 shares. The 1st downside support level on ATRA is $13.16 and the 1st resistance level on ATRA is $18.58. ATRA fifty day moving average is $11.05 and ATRA two hundred day moving average is $11.83.

Atara Biotherapeutics, Inc. (ATRA) most current performance has been specified by the recent movement in ATRA common shares. ATRA has performed 25.97% over the past 4 weeks, ATRA has performed 45.44% over the past 3 months and ATRA has shown -26.40% over the past 1 year. Atara Biotherapeutics, Inc. (ATRA) has a 12 month range of $4.52 to $21.45. Atara Biotherapeutics, Inc. (ATRA) is trading 210.18% from its 12 month low and -34.64% from its 12 month high. Atara Biotherapeutics, Inc. (ATRA) is showing a 27.75% short float showing the sum short in the float.

ATRA has 61.21M shares outstanding and 42.76M shares in the float. Atara Biotherapeutics, Inc. (ATRA) currently has a market cap of $1.02B and income of -298.20M. The EPS next quarter for ATRA is -1.23 and anticipated EPS next year is 12.70%. The market cap of Atara Biotherapeutics, Inc. (ATRA) at $1.02B represents how many Investors own shares of ATRA and is calculated off the last price ($14.02) of ATRA and the sum of shares outstanding (61.21M) with Atara Biotherapeutics, Inc. (ATRA).

Atara Biotherapeutics, Inc. (ATRA) has aggregate cash (mrq) of 214.63M, aggregate cash per share (mrq) of 3.64, aggregate debt of ATRA remains at 13.81M and aggregate debt/equity (mrq) is 5.46. . Atara Biotherapeutics, Inc. (ATRA) operating cash flow (ttm) is -232.47M, ATRA leveraged free cash flow (ttm) is -129.68M.

ATRA is trading 31.61% above (bullish) its SMA20, 38.08% above (bullish) its SMA50 and 13.30% above (bullish) its SMA200.